The effect of a geriatric evaluation on treatment decisions for older cancer patients-a systematic review

Acta Oncologica

Volumn 53, Issue 3, 2014, Pages 289-296

  Hamaker, Marije E ^a   Schiphorst, Anandi H ^a   Ten Bokkel Huinink, Daan ^a   Schaar, Cees ^b   Van Munster, Barbara C ^b,c  

^a DEPARTMENT OF SURGERY   (Netherlands)

^b GELRE HOSPITALS   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADL DISABILITY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER THERAPY; CAREGIVER BURDEN; CLINICAL DECISION MAKING; COGNITIVE DEFECT; COMORBIDITY; CONSULTATION; DEPRESSION; GERIATRIC ASSESSMENT; HEALTH CARE PERSONNEL; HUMAN; NURSE; NUTRITIONAL STATUS; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; SYSTEMATIC REVIEW; TREATMENT PLANNING; FRAIL ELDERLY; INTENSIVE CARE; MEDICAL SPECIALIST;

AGED; AGED, 80 AND OVER; GERIATRIC ASSESSMENT; HUMANS; NEOPLASMS; REFERRAL AND CONSULTATION;

EID: 84894220844     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2013.840741     Document Type: Review

References (30)

1. Taylor C, Munro AJ, Glynne-Jones R, Griffith C, Trevatt P, Richards M, et al. Multidisciplinary team working in cancer: What is the evidence? Br Med J 2010;340:c951.
2. Saini KS, Taylor C, Ramirez AJ, Palmieri C, Gunnarsson U, Schmoll HJ, et al. Role of the multidisciplinary team in breast cancer management: Results from a large international survey involving 39 countries. Ann Oncol 2012; 23:853-9.
3. Hutchins LF, Unger JM, Crowley JJ, Coltman CA, Jr., Albain KS. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 1999;341: 2061-7.
4. Bellera C, Praud D, Petit-Moneger A, McKelvie-Sebilau P, Soubeyran P, Mathoulin-Pelissier S. Barriers to inclusion of older adults in randomised controlled clinical trials on Non-Hodgkins lymphoma: A systematic review. Cancer Treat Rev 2013;39:812-7.
5. Lewis JH, Kilgore ML, Goldman DP, Trimble EL, Kaplan R, Montello MJ, et al. Participation of patients 65 years of age or older in cancer clinical trials. J Clin Oncol 2003; 21:1383-9.
6. Extermann M, Aapro M, Bernabei R, Cohen HJ, Droz JP, Lichtman S, et al. Use of comprehensive geriatric assessment in older cancer patients: Recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hematol 2005;55: 241-52.
7. Wells GA, Shea B, OConnell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottowa Scale (NOS) for assessing the quality of nonrandomized studies in metaanalysis. Available from: www.ohri.ca/programs/clinical- epidemiology/oxford.asp [cited 2012 Nov 21].
8. Aliamus V, Adam C, Druet-Cabanac M, Dantoine T, Vergnenegre A. Geriatric assessment contribution to treatment decision-making in thoracic oncology. Rev Mal Respir 2011;29:1124-30.
9. Aparicio T, Girard L, Bouarioua N, Patry C, Legrain S, Soule JC. A mini geriatric assessment helps treatment decision in elderly patients with digestive cancer. A pilot study. Crit Rev Oncol Hematol 2011;77:63-9.
10. Caillet P, Canoui-Poitrine F, Vouriot J, Berle M, Reinald N, Krypciak S, et al. Comprehensive geriatric assessment in the decision-making process in elderly patients with cancer: ELCAPA study. J Clin Oncol 2011;29:3636-42.
11. Chaibi P, Magne N, Breton S, Chebib A, Watson S, Duron J-J, et al. Influence of geriatric consultation with comprehensive geriatric assessment on final therapeutic decision in elderly cancer patients. Crit Rev Oncol Hematol 2011;79:302-7.
12. Extermann M, Meyer J, McGinnis M, Crocker TT, Corcoran MB, Yoder J, et al. A comprehensive geriatric intervention detects multiple problems in older breast cancer patients. Crit Rev Oncol Hematol 2004;49:69-75.
13. Frennet M, Kerger J, Cornette P, Humblet Y, Lesage V, de Saint-Hubert M. Impact of comprehensive geriatric assessment (CGA) during oncologic treatment in frail elderly patients. Eur Geriatr Med 2011;2:S35.
14. Girre V, Falcou M-C, Gisselbrecht M, Gridel G, Mosseri V, Bouleuc C, et al. Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? J Gerontol A Biol Sci Med Sci 2008;63:724-30.
15. Horgan AM, Leighl NB, Coate L, Liu G, Palepu P, Knox JJ, et al. Impact and feasibility of a comprehensive geriatric assessment in the oncology setting: A pilot study. Am J Clin 2012;35:322-8.
16. Kenis C, Bron D, Libert Y, Decoster L, Van PK, Scalliet P, et al. Relevance of a systematic geriatric screening and assessment in older patients with cancer: Results of a prospective multicentric study. Ann Oncol 2013;24: 1306-12.
17. Weltermann A, Koller H. Diagnostic yield of a geriatric assessment and a standardized intervention plan in elderly patients with newly diagnosed cancer: A cohort study. Onkologie 2011;34:228.
18. Lamb BW, Taylor C, Lamb JN, Strickland SL, Vincent C, Green JS, et al. Facilitators and barriers to teamworking and patient centeredness in multidisciplinary cancer teams: Findings of a national study. Ann Surg Oncol 2013;20: 1408-16.
19. Lamb BW, Sevdalis N, Benn J, Vincent C, Green JS. Multidisciplinary cancer team meeting structure and treatment decisions: A prospective correlational study. Ann Surg Oncol 2013;20:715-22.
20. Wedding U, Kodding D, Pientka L, Steinmetz HT, Schmitz S. Physicians judgement and comprehensive geriatric assessment (CGA) select different patients as fit for chemotherapy. Crit Rev Oncol Hematol 2007; 64:1-9.
21. Hoeben KW, van Steenbergen LN, van de Wouw AJ, Rutten HJ, Van Spronsen DJ, Janssen-Heijnen ML. Treatment and complications in elderly stage III colon cancer patients in the Netherlands. Ann Oncol 2013;24: 974-9.
22. Hamaker ME, Jonker JM, de Rooij SE, Vos AG, Smorenburg CH, van Munster BC. Frailty screening tools for predicting outcome of a comprehensive geriatric assessment in older cancer patients. Lancet Oncol 2012;13: e437-44.
23. Hamaker ME, Vos AG, Smorenburg CH, de Rooij SE, van Munster BC. The value of geriatric assessments in predicting treatment tolerance and all-cause mortality in older cancer patients. Oncologist 2012;17:1439-49.
24. Hamaker ME, Seynaeve C, Wymenga ANM, van Tinteren H, Nortier.WR, Maartense E, et al. Baseline comprehensive geriatric assessment to predict for toxicity of singleagent chemotherapy in elderly metastatic breast cancer patients: Results from the OMEGA study of the Dutch Breast Cancer Trialists. Group. J Clin Oncol 2012;30(suppl abstr 1080):15.
25. Audisio RA, Osman N, Audisio MM, Montalto F. How do we manage breast cancer in the elderly patients? A survey among members of the British Association of Surgical Oncologists (BASO). Crit Rev Oncol Hematol 2004;52:135-41.
26. National Health Service - National Institute for Clinical Excellence guidances. Available from: www.nice.org.uk [cited 2012 Nov 5].
27. Mitchell AJ, Bird V, Rizzo M, Meader N. Diagnostic validity and added value of the Geriatric Depression Scale for depression in primary care: A meta-analysis of GDS30 and GDS15. J Affect Disord 2010;125:10-7.
28. Rao AV, Hsieh F, Feussner JR, Cohen HJ. Geriatric evaluation and management units in the care of the frail elderly cancer patient. J Gerontol A Biol Sci Med Sci 2005; 60:798-803.
29. Extermann M, Boler I, Reich RR, Lyman GH, Brown RH, Defelice J, et al. Predicting the risk of chemotherapy toxicity in older patients: The Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score. Cancer 2012;118:3377-86.
30. Hurria A, Togawa K, Mohile SG, Owusu C, Klepin HD, Gross CP, et al. Predicting chemotherapy toxicity in older adults with cancer: A prospective multicenter study. J Clin Oncol 2011;29:3457-65.